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Summary
Objectives: This study examined the association between lymphocyte subgroups andmortality in
patients with Crimean-Congo hemorrhagic fever (CCHF) in Turkey.
Methods: During the spring and summer of 2007, peripheral blood was collected from hospita-
lized patients with suspected CCHF. Lymphocyte subgroups were characterized by fluorescence-
activated cell sorting. CCHF cases were confirmed by detecting viral RNA by PCR and/or IgM
antibodies by ELISA. Lymphocyte subgroups were compared between fatal and non-fatal cases.
The correlation between lymphocyte subgroups and viral loads was also investigated.
Results: Seventy-seven confirmed cases of CCHF were included in this study (five cases were fatal
(6.5 %)). No differences in lymphocyte subgroups were found between fatal and non-fatal cases,
except for significantly higher CD3+CD8+ T cells in the fatal cases ( p = 0.017). A positive
correlation between viral load and CD3+CD8+ T cells was also detected ( p = 0.044). There
was no correlation between other lymphocyte subgroups and viral load.
Conclusions: Higher levels of CD3+CD8+ T lymphocytes were detected in fatal compared to non-
fatal CCHF cases. Despite this cytotoxic immune activation, a fatal outcome could not be
prevented. We hypothesize that high viral load and other factors may influence this outcome,
although more studies are required to explain the pathogenesis of CCHF.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a tick-born dis-
ease caused by Nairovirus, of the family of Bunyaviridae.1 It* Corresponding author. Tel.: +90 312 5084842.
E-mail address: esragulakinci@yahoo.com (E. Akıncı).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.08.027is a potentially fatal disease and is endemic in Africa, the
Middle East, Central Asia, and Eastern Europe.2—4 Since 2002,
large outbreaks have also been seen in the middle, northern,
and eastern regions of Turkey during spring and summer
seasons.5—11 Common clinical signs of CCHF include fever,
nausea, headache, diarrhea, myalgia, petechial rash, and
bleeding.4 Leukopenia is also detected in most patients withPublished by Elsevier Ltd. All rights reserved.
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subgroups affected by CCHF and their association with mor-
tality of the disease. In the present study, the association
between the lymphocyte subgroups and mortality was inves-
tigated in patients with CCHF.
Patients and methods
This prospective study was conducted at Ankara Numune
Education and Research Hospital, a referral and tertiary-care
hospital in Turkey. The local medical ethics committee
approved the study, and all patients included in the study
gave informed consent. During the spring and summer
seasons of 2007, patients were admitted to the hospital with
a possible case of CCHF if they had epidemiological risk
factors (residence in an endemic area and/or history of a
tick-bite) and had clinical signs and laboratory findings
(fever, nausea and vomiting, headache, diarrhea, myalgia,
petechiae, bleeding, leukopenia, thrombocytopenia, and
elevated levels of transaminase, lactate dehydrogenase,
and creatine phosphokinase) compatible with CCHF. Periph-
eral blood samples were collected in the first 72 hours fol-
lowing admission to detect lymphocyte subgroups, and were
tested within two hours after the collection of the samples.
CCHF cases were confirmed by a serum PCR test to detect
CCHF viral RNA and/or the presence of CCHF-specific serum
IgM antibodies determined by ELISA. Confirmed cases of CCHF
were included in the study. The other possible causes of
infections such as brucellosis, salmonellosis, viral hepatitis,
TORCH infections, leptospirosis, and Mediterranean spotted
fever were excluded by serological tests. In all of the
patients, blood cultures were negative and no focal infection
sites were detected.
The TaqMan-based 1-step reverse transcriptase PCR
assay was used for the detection and quantification of CCHF
viral RNA.12 To detect the CCHF-specific serum IgM anti-
bodies, in-house ELISA tests were performed at the national
reference laboratory; the antigens used in the tests were
obtained from the Centers for Disease Control and Preven-
tion (CDC).
Peripheral blood samples were collected in tubes contain-
ing ethylenediaminetetraacetic acid (EDTA). Peripheral blood
lymphocyte subgroups were examined using a panel of mono-
clonal antibodies (MoAbs) by lysedwhole blood technique. The
following combinations of mouse antihuman MoAbs were used
for two- or three-color staining: CD45FITC/CD14PE,
CD3ECD/CD4FITC/CD8PE, CD3FITC/CD16+56PE,
CD3FITC/HLA DRPE, CD3FITC/CD19PE (Beckman Coul-Table 1 Lymphocyte subgroups in the fatal and non-fatal cases.
Lymphocyte subgroups Fatal cases (n = 5)
Mean  SD value, %
CD3 71.2  7
CD19 13  6.3
CD3+CD4+ 37  5
CD3+CD8+ 32  7
CD3CD16+56+ 8.8  8.2
CD3HLA DR+ 11.4  7.1
CD3+HLA DR+ 13.4  10ter). Phycoerythrin (PE), fluorescein isothiocyanate (FITC),
phycoerythrin—Texas Red (ECD)-labeled Mouse IgG of the
appropriate isotypes was used as negative control in all of
the studies. Data were analyzed using Coulter system CXP
software for the Beckman Coulter FC-500. Lymphocytes were
gated in CD45FITC versus side scatter plot (10 000 events in
this gate were acquired) and these were further analyzed for
expression of CD3 (Tcells), CD19 (B cells), CD3+CD4+ (T helper
cells), CD3+CD8+ (T cytotoxic cells), CD3CD16+56+ (natural
killer cells), and CD3HLA DR+ and CD3+HLA DR+ (active T
cells).
The clinical course and laboratory data of the patients
were recorded prospectively on individual forms. The per-
ipheral blood lymphocyte subgroups were compared
between the fatal and non-fatal cases. The correlation
between lymphocyte subgroups and viral load was also inves-
tigated.
Statistical analyses were performed using SPSS 10.0 (SPSS
Inc., Chicago, Illinois) statistical package. The Kolmogorov—
Smirnov test was used to check the normality of distribution.
For continuous variables, differences were compared with
the Student’s t-test. The Chi-square test or Fisher’s exact
test was used for comparisons between groups. The associa-
tion between viral load and T lymphocyte subtypes was
assessed by Pearson correlation coefficient.
Results
Seventy-seven confirmed cases with positive serum PCR and/
or IgM ELISA tests for CCHF, were included in the study. Five of
the 77 subjects with CCHF (6.5%) died, while the remaining
72 patients (93.5%) survived.
Of the 77 patients included in this study, 60 (77.9%) had
CCHF viral RNA detected by PCR and 69 (89.6%) had CCHF-
specific IgM antibodies detected by ELISA. Most of these cases
(79.2%) handled livestock, and half of them (53.2%) had a
history of tick-bite. All of the patients were living in endemic
areas within Turkey and 38 (49.4%) of them were male. The
mean age of the patients was 44.3 (range 15—50) years and
mean duration of symptoms was 6 (range 1—20) days.
Lymphocyte subgroups were studied for all of the
patients. The difference in the lymphocyte subgroups was
not statistically significant between fatal and non-fatal
cases, except for CD3+CD8+ T cells (Table 1). Cytotoxic T
cells (CD3+CD8+) were significantly higher in the fatal cases
( p = 0.017). A correlation between viral load and CD3+CD8+ T
cells was also detected. As the viral load increased,
CD3+CD8+ T cells increased ( p = 0.044) (Figure 1). ThereNon-fatal cases (n = 72)
Mean  SD value, %
p-Value
60.9  12.1 0.066
15.3  9.7 0.600
35.6  8.6 0.714
23.2  8 0.017
12.8  6.9 0.216
18.4  10.9 0.164
9.2  8.1 0.271
Figure 1 Correlation between viral load and CD3+CD8+ Tcells.
As the viral load increases, CD3+CD8+ T cells increase
(p = 0.044).
562 E. Akıncı et al.was no correlation between the other lymphocyte subgroups
and viral load ( p > 0.05) (Table 2).
Discussion
CCHF is a severe disease with a reported mortality rate of
3—30%. Activation of immune responses and vascular
damage have been detected in hemorrhagic fever virus
infections.13
There are limited data on the pathogenesis of CCHF. It has
been demonstrated that interleukin-6 (IL-6) and tumor
necrosis factor-alpha (TNF-a) are the cytokines mostly
induced during the infection, and levels have been found
to be higher in patients with fatal CCHF.14,15 High levels of
neopterin (a marker of cellular immune activation) and
increased viral load have also been associated with mortal-
ity.11,16 It has been suggested that hemophagocytosis occurs
in patients with CCHF and has a role in the development of
pancytopenia.7
Leukopenia is common in CCHF. However, data on the
lymphocyte subgroups affected by CCHF and their associa-
tion with mortality are limited. We found only one pub-
lished study examining the lymphocyte subgroups in CCHF.
In this study, natural killer (NK) cells were significantly
higher in patients with severe CCHF, and a positive correla-Table 2 Correlation coefficients between viral load and lympho
Lymphocyte subtype
CD3+CD4+ CD3+CD8+
Log10 viral load
Pearson correlation 0.157 0.261
p-Value 0.230 0.044tion was found between NK cell counts and serum levels of
aspartate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) and activated partial thromboplastin times
(aPTT).17 Therefore, it was suggested that elevated NK cell
counts may serve as a prognostic marker in patients with
CCHF. However in our study, although NK cells were less
increased in fatal cases, there was no statistically signifi-
cant difference between the fatal and non-fatal cases. We
considered that the innate immune system might be sup-
pressed in fatal cases leaving insufficient time for the
activation of adaptive immunity. However, the numbers
of fatal or severe cases are too low in both studies for
any definite conclusions to be drawn. Thus we need more
studies with higher numbers of patients.
Several studies have examined the lymphocyte sub-
groups in patients with other types of hemorrhagic fevers.
In the lethal mouse Ebola model of Bradfute et al., it was
shown that there is an increase in the expression of the
activation and maturation marker CD44 in both CD4+ and
CD8+ T cells late in infection, which suggests that there is
lymphocyte activation despite apoptosis.18 Furthermore,
although functional immune responses occur in this murine
model, the infection still kills the host. Several possible
explanations were provided as to why this immune response
was insufficient for survival.18 First, the response may occur
too late to control the rapidly replicating virus and the
number of CD3+CD8+ Tcells could be too low to control the
high viral titers. Second, the immune response could be
dampened by altered cytokine production. Third, the
damage done by infection could be too severe to be over-
come at the time the adaptive immune response is acti-
vated. In dengue virus infection, another model of
hemorrhagic fever, an increase in CD3+CD8+ T lymphocytes
and CD4/CD8 inversion has been detected.19 The inversion
was found to be significantly higher in dengue hemorrhagic
fever and dengue shock syndrome than the dengue fever. In
the present study, the levels of CD3+CD8+ T lymphocytes
were higher in fatal CCHF cases than non-fatal cases. This
shows that cytotoxic immune responses were activated in
CCHF. However, despite this activation, a fatal outcome
could not be prevented. We hypothesize that the high viral
load, as well as other additional factors, might have influ-
enced the outcome.
In conclusion, the pathogenesis of CCHF remains unclear.
This study suggests that the cytotoxic T cell response
increases lymphocyte subgroups in fatal CCHF cases, and
that this correlates with the elevated viral load. However,
the Tcell response may be too late or insufficient to prevent
death. More studies are required to explain the pathogenesis
of CCHF.
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